IRIDEX Long Term Debt 2010-2023 | IRIX

IRIDEX long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
IRIDEX Annual Long Term Debt
(Millions of US $)
2023 $
2022 $
2021 $
2020 $1
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
IRIDEX Quarterly Long Term Debt
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31 $0
2020-12-31 $1
2020-09-30 $1
2020-06-30 $1
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Computer and Technology Laser Systems and Components $0.046B $0.052B
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
Stock Name Country Market Cap PE Ratio
IPG Photonics (IPGP) United States $3.807B 21.53
Lumentum Holdings (LITE) United States $2.933B 207.24
Applied Energetics (AERG) United States $0.419B 0.00
Microvision (MVIS) United States $0.305B 0.00
Cutera (CUTR) United States $0.049B 0.00